Anti-angiogenesis: making the tumor vulnerable to the immune system (Q37148358)

18 August 2017

7 references

3 April 2019

19 June 2019

25 June 2019

9 September 2020

8 February 2021

7 April 2021

13 January 2024

Anti-angiogenesis: making the tumor vulnerable to the immune system (English)

1 reference

18 August 2017

2 references

3 April 2019

19 June 2019

0 references

1 reference

8 February 2021

1 reference

7 April 2021

1 reference

1

Arjan W Griffioen

1 reference

18 August 2017

26 April 2008

1 reference

PMC publication ID

2491426

Cancer Immunology, Immunotherapy

18 August 2017

1 October 2008

6 references

3 April 2019

19 June 2019

25 June 2019

8 February 2021

7 April 2021

13 January 2024

8 references

18 August 2017

3 April 2019

19 June 2019

25 June 2019

9 September 2020

8 February 2021

7 April 2021

13 January 2024

57

1 reference

18 August 2017

10

1 reference

18 August 2017

1553-1558

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

18 August 2017

2 references

7 April 2021

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

13 January 2024

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiogenesis in life, disease and medicine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiogenic profile of breast carcinoma determines leukocyte infiltration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiogenesis in cancer, vascular, rheumatoid and other disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Tumor angiogenesis factors reduce leukocyte adhesion in vivo.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Angiostatic activity of DNA methyltransferase inhibitors

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491426

Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors

3 September 2018

1 reference

12 December 2020

Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta

1 reference

12 December 2020

Diminished leukocyte-endothelium interaction in tumor microvessels

1 reference

12 December 2020

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma

1 reference

12 December 2020

Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors

1 reference

12 December 2020

Angiogenesis inhibitors overcome tumor induced endothelial cell anergy

1 reference

12 December 2020

During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

1 reference

12 December 2020

[Angiogenesis and the regulation of antitumor defense]

1 reference

12 December 2020

Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan

1 reference

12 December 2020

Rocking the foundations of solid tumor growth by attacking the tumor's blood supply

1 reference

12 December 2020

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

1 reference

12 December 2020

Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium

1 reference

12 December 2020

Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications

1 reference

12 December 2020

The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions

1 reference

12 December 2020

Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells

1 reference

12 December 2020

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression

1 reference

12 December 2020

10.1007/S00262-008-0524-3

Identifiers

DOI

1 reference

18 August 2017

1 reference

PMC publication ID

2491426

18 August 2017

PubMed publication ID

18438662

1 reference

PMC publication ID

2491426